Status:
UNKNOWN
Study on the Application of Saliva EBV-DNA Detection in EBV Infection Related Diseases
Lead Sponsor:
Beijing Friendship Hospital
Conditions:
EBV Infection
Eligibility:
All Genders
3-65 years
Brief Summary
This study is a single-center, prospective, observational clinical study to evaluate the Application of saliva EBV-DNA Detection in EBV Infection Related Diseases
Eligibility Criteria
Inclusion
- According to the HLH-04 diagnostic criteria, it meets the HLH diagnostic criteria. EBV infection occurs in cells with EBV-DNA copy number significantly increased in peripheral blood or tissue, or where EBV coding small RNA(EBER) is detected in tissue or peripheral blood. Or Straus' 1988 diagnostic criteria for CAEBV.
- Informed consent
Exclusion
- Patients who cannot cooperate with saliva collection
- Patients who are unwilling to cooperate with the project research according to the project research plan.
Key Trial Info
Start Date :
March 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04782674
Start Date
March 15 2021
End Date
April 1 2022
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100050